Please login to the form below

Not currently logged in
Email:
Password:

Eric Rhodes becomes CEO of ERS Genomics

Succeeds the company’s founder Shaun Foy in the role

ERS Genomics Eric RhodesERS Genomics, an Irish biotechnology firm, has appointed Eric Rhodes as its new chief executive officer.

He replaces co-founder Shaun Foy in the lead role, who will continue on with the company as chairman of the board.

Rhodes joins ERS Genomics from Horizon Discovery, where he served as senior vice president of research and development and chief technology officer.

In these roles, Rhodes was responsible for commercialising the company's genome editing technologies as well as driving its research and development.

Prior to joining Horizon Discovery, Rhodes held a number of senior positions including director of business development at Sigma-Aldrich and vice president of business development and alliance management at Sangamo Biosciences.

Foy said: “With his deep understanding of the gene-editing landscape and extensive experience in marketing and commercialising gene-editing technologies, Eric is a perfect fit to help ERS Genomics accelerate our commercialisation activities.

“We are excited to welcome him to the team.”

10th June 2016

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...

Infographics